James G Chun, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 35 years
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 1991
Offices
1 location · Cardiovascular Medical Group · 8 clinicians in this group
Looking this up.
Hospitals listed: UCSF Health Hyde Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chun’s office at (415) 933-9100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G75949 · Current
Licensed to practise in California · since 1993 · expires 2028-11-30 · Umdnj Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$138,077
Medicare paid this office $138,077 for 372 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 218 | $40,356 | $101 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $12,514 | $232 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 46 | $8,764 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $8,687 | $66 |
| New patient visit (45+ min) | 52 | $6,602 | $127 |
See all 15 services
| Return visit (30+ min) | 218 | $40,356 | $101 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $12,514 | $232 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 46 | $8,764 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $8,687 | $66 |
| New patient visit (45+ min) | 52 | $6,602 | $127 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $5,242 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $5,047 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 50 | $4,581 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,695 | $193 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $1,373 | $92 |
| Heart muscle strain imaging | 31 | $1,186 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 63 | $1,003 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 22 | $539 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 22 | $300 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $260 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 11 | More than 29% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
372 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 27% · Women 43% · Also on Medicaid 53% · Health risk score 1.90. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 51% · Coronary heart disease 46% · Chronic kidney disease 43% · Atrial fibrillation 36% · Heart failure 35% · Depression 21% · Dementia 20% · COPD 19% · Stroke 16% · Cancer 15%.
The office billed $529,830, Medicare allowed $192,977 and paid $138,077; for 1,333 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 372 | 1,333 | 78 | 1.90 | $529,830 | $138,077 |
| 2023 | 389 | 1,737 | 79 | 1.85 | $543,790 | $138,707 |
| 2022 | 474 | 2,223 | 79 | 1.72 | $623,534 | $158,798 |
| 2021 | 426 | 2,400 | 79 | 1.73 | $589,835 | $143,507 |
| 2020 | 373 | 1,387 | 78 | 1.94 | $438,406 | $98,236 |
| 2019 | 405 | 1,082 | 78 | 1.90 | $402,030 | $94,526 |
| 2018 | 344 | 1,092 | 78 | 1.76 | $371,705 | $81,890 |
| 2017 | 313 | 903 | 78 | 1.65 | $288,550 | $73,820 |
| 2016 | 326 | 981 | 78 | 1.67 | $360,650 | $83,359 |
| 2015 | 324 | 998 | 78 | 1.59 | $351,550 | $83,463 |
| 2014 | 363 | 1,073 | 78 | 1.76 | $389,600 | $95,211 |
| 2013 | 379 | 1,162 | 78 | 1.70 | $439,900 | $98,838 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Return visit (30+ min) | 237 | $44,269 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $12,818 | $203 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,571 | $233 |
| New patient visit (45+ min) | 67 | $8,805 | $131 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $8,052 | $474 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $6,899 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,760 | $103 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 46 | $4,451 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,943 | $58 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,825 | $201 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $2,399 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 35 | $2,136 | $61 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $1,694 | $89 |
| Heart muscle strain imaging | 31 | $1,211 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 73 | $1,142 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 19 | $568 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 19 | $304 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $292 | $11 |
2022: 20 services
| Return visit (30+ min) | 267 | $46,636 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 74 | $14,501 | $191 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 61 | $14,103 | $231 |
| New patient visit (45+ min) | 91 | $11,035 | $121 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $8,282 | $460 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 77 | $7,511 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $6,714 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 107 | $6,244 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,240 | $212 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 47 | $3,808 | $49 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $2,407 | $71 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 37 | $2,272 | $61 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 19 | $2,022 | $101 |
| Short return visit (20+ min) | 13 | $1,074 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | $755 | $13 |
| New patient visit (30+ min) | 11 | $589 | $54 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $480 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $334 | $11 |
| Heart rhythm recording of continous external ekg over 8-15 days | 15 | $300 | $14 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 18 | $232 | None |
2021: 18 services
| Return visit (30+ min) | 232 | $43,040 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $17,658 | $203 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $12,592 | $504 |
| New patient visit (45+ min) | 85 | $11,825 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $6,613 | $108 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 68 | $5,725 | $31 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $5,203 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,906 | $245 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,624 | $220 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | $4,613 | $92 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 49 | $4,119 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 54 | $3,742 | $69 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $2,057 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $957 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $773 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 24 | $472 | $16 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 25 | $415 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $338 | $11 |
2020: 16 services
| Return visit (30+ min) | 196 | $27,176 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $13,358 | $206 |
| New patient visit (45+ min) | 56 | $6,788 | $121 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $5,334 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $5,044 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,632 | $221 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 59 | $4,123 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 48 | $3,367 | $69 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,974 | $198 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 43 | $2,866 | $42 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $1,574 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 63 | $1,270 | $16 |
| Short return visit (20+ min) | 13 | $716 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $242 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $202 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $136 | $11 |
2019: 13 services
| Return visit (30+ min) | 207 | $29,359 | $84 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 58 | $12,986 | $224 |
| New patient visit (45+ min) | 56 | $7,641 | $136 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $5,141 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,521 | $226 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,497 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $4,192 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $4,172 | $209 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 39 | $2,696 | $38 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,259 | $105 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 17 | $1,177 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 36 | $625 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $307 | $11 |
2018: 16 services
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 57 | $12,794 | $213 |
| Short return visit (20+ min) | 159 | $12,557 | $49 |
| Return visit (30+ min) | 85 | $8,702 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 72 | $5,225 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,760 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $4,382 | $58 |
| New patient visit (45+ min) | 26 | $3,489 | $134 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $3,159 | $186 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,569 | $184 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,859 | $143 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 36 | $1,617 | $29 |
| Programming of dual lead pacemaker system | 24 | $1,273 | $51 |
| New patient visit (30+ min) | 23 | $1,257 | $55 |
| Short return visit (20+ min) | 13 | $540 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $341 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $323 | $10 |
2017: 10 services
| Short return visit (20+ min) | 182 | $20,733 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $14,577 | $265 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $6,159 | $220 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $6,121 | $115 |
| New patient visit (30+ min) | 42 | $3,853 | $92 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 47 | $3,026 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 56 | $2,793 | $49 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 44 | $2,409 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $445 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $131 | $11 |
2016: 13 services
| Short return visit (20+ min) | 183 | $19,922 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 57 | $15,811 | $268 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,406 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $4,293 | $49 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $3,257 | $233 |
| New patient visit (30+ min) | 32 | $2,884 | $90 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 50 | $2,572 | $30 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 38 | $2,560 | $33 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $2,214 | $201 |
| Short return visit (20+ min) | 22 | $1,168 | $45 |
| Return visit (30+ min) | 11 | $902 | $82 |
| Return visit (30+ min) | 13 | $898 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $586 | $15 |
2015: 10 services
| Short return visit (20+ min) | 175 | $20,047 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 56 | $15,253 | $268 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,322 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 22 | $5,039 | $229 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 39 | $4,024 | $34 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $3,602 | $47 |
| New patient visit (30+ min) | 40 | $3,463 | $87 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 44 | $2,462 | $31 |
| Return visit (30+ min) | 19 | $1,725 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $628 | $15 |
2014: 20 services
| Short return visit (20+ min) | 194 | $22,165 | $58 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $8,993 | $281 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $7,159 | $231 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $6,272 | $116 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,182 | $562 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,424 | $452 |
| New patient visit (30+ min) | 45 | $3,964 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $3,693 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,522 | $52 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,875 | $221 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,868 | $261 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 49 | $2,634 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,529 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,187 | $64 |
| Return visit (30+ min) | 21 | $1,820 | $87 |
| Initial hospital observation care per day, typically 50 minutes | 14 | $1,299 | $93 |
| Hospital observation care on day of discharge | 12 | $722 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $394 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $185 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $131 | $12 |
2013: 16 services
| Short return visit (20+ min) | 188 | $22,637 | $58 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,979 | $232 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,853 | $114 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,950 | $458 |
| New patient visit (30+ min) | 64 | $5,529 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 28 | $5,423 | $187 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,417 | $451 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $3,725 | $34 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $3,471 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $3,310 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,163 | $176 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 56 | $2,793 | $30 |
| Return visit (30+ min) | 28 | $2,500 | $89 |
| Initial hospital observation care per day, typically 50 minutes | 14 | $1,749 | $117 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $825 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $542 | $16 |
Medicaid work
$12,420 in 2024
Medicaid paid $12,420 for 107 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 107 | $12,420 |
| 2024 | 107 | 1 | 21 | $12,420 |
| 2023 | 140 | 2 | 28 | $22,113 |
| 2022 | 27 | 2 | 14 | $2,058 |
| 2021 | 30 | 2 | 15 | $903 |
| 2019 | 12 | 1 | 12 | $0 |
| 2018 | 56 | 2 | 17 | $125 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 127 | $18,081 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $4,032 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $1,480 |
| Return visit (30+ min) | 15 | $578 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $686 |
| Return visit (30+ min) | 15 | $218 |
2019
| Return visit (30+ min) | 12 | $0 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $125 |
| Short return visit (20+ min) | 44 | $0 |
Drugs they prescribed that Part D paid
$907,403
Pharmacies billed $907,403 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,975) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,339 generic and 636 brand-name prescriptions · $907,403 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 231 | $326,921 | $1,415 |
| Xarelto | 187 | $268,988 | $1,438 |
| Entresto | 59 | $81,578 | $1,383 |
| Multaq | 32 | $61,554 | $1,924 |
| Jardiance | 28 | $44,299 | $1,582 |
See all 36 drugs
| Eliquis | 231 | $326,921 | $1,415 |
| Xarelto | 187 | $268,988 | $1,438 |
| Entresto | 59 | $81,578 | $1,383 |
| Multaq | 32 | $61,554 | $1,924 |
| Jardiance | 28 | $44,299 | $1,582 |
| Farxiga | 30 | $40,172 | $1,339 |
| Brilinta | 15 | $16,556 | $1,104 |
| Amiodarone | 77 | $4,103 | $53 |
| Metoprolol | 290 | $3,932 | $14 |
| Ezetimibe | 127 | $3,076 | $24 |
| Atorvastatin | 324 | $2,770 | $9 |
| Rosuvastatin | 98 | $2,311 | $24 |
| Labetalol | 24 | $1,865 | $78 |
| Clopidogrel | 123 | $1,498 | $12 |
| Losartan | 148 | $1,191 | $8 |
| Amlodipine Besylate | 211 | $1,151 | $5 |
| Carvedilol | 115 | $919 | $8 |
| Losartan-Hydrochlorothiazide | 47 | $714 | $15 |
| Pravastatin | 49 | $626 | $13 |
| Pantoprazole | 52 | $590 | $11 |
| Diltiazem 24hr Er (Cd) | 23 | $590 | $26 |
| Furosemide | 115 | $476 | $4 |
| Isosorbide Mononitrate Er | 23 | $463 | $20 |
| Lisinopril | 53 | $362 | $7 |
| Simvastatin | 53 | $326 | $6 |
| Warfarin | 11 | $278 | $25 |
| Spironolactone | 24 | $232 | $10 |
| Metoprolol | 24 | $205 | $9 |
| Irbesartan | 11 | $183 | $17 |
| Hydralazine | 14 | $183 | $13 |
| Torsemide | 11 | $176 | $16 |
| Nitroglycerin | 19 | $175 | $9 |
| Chlorthalidone | 17 | $173 | $10 |
| Metformin | 16 | $157 | $10 |
| Nifedipine Er | 12 | $155 | $13 |
| Hydrochlorothiazide | 35 | $43 | $1 |
Year by year
| 2024 | 2,975 | 412 | 0% (0) | 21% | $907,403 |
| 2023 | 3,111 | 431 | 0% (0) | 19% | $926,297 |
| 2022 | 2,788 | 416 | 0% (0) | None | $705,653 |
| 2021 | 2,351 | 388 | 0% (0) | 17% | $542,548 |
| 2020 | 1,918 | 336 | 0% (0) | 18% | $429,636 |
| 2019 | 1,428 | 278 | 0% (0) | 21% | $315,989 |
| 2018 | 1,353 | 233 | 0% (0) | 20% | $268,121 |
| 2017 | 1,411 | 245 | None | 17% | $186,051 |
| 2016 | 1,423 | 229 | 0% (0) | 18% | $178,542 |
| 2015 | 1,543 | 247 | 1% (17) | 19% | $164,955 |
| 2014 | 1,643 | 249 | 2% (27) | 17% | $129,059 |
| 2013 | 1,784 | 261 | 1% (18) | 18% | $126,007 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Eliquis | 212 | $308,091 | $1,453 |
| Xarelto | 191 | $269,686 | $1,412 |
| Entresto | 56 | $90,502 | $1,616 |
| Multaq | 35 | $71,343 | $2,038 |
| Farxiga | 20 | $35,759 | $1,788 |
| Metoprolol | 311 | $7,540 | $24 |
| Atorvastatin | 348 | $7,419 | $21 |
| Ezetimibe | 123 | $7,040 | $57 |
| Praluent | 11 | $5,960 | $542 |
| Amiodarone | 98 | $5,728 | $58 |
| Amlodipine Besylate | 236 | $3,191 | $14 |
| Clopidogrel | 144 | $3,061 | $21 |
| Rosuvastatin | 99 | $3,015 | $30 |
| Losartan | 152 | $2,472 | $16 |
| Labetalol | 24 | $2,377 | $99 |
| Carvedilol | 125 | $2,294 | $18 |
| Nifedipine Er | 14 | $1,508 | $108 |
| Pantoprazole | 60 | $1,497 | $25 |
| Losartan-Hydrochlorothiazide | 58 | $1,452 | $25 |
| Metolazone | 11 | $1,258 | $114 |
| Diltiazem 24hr Er (Cd) | 22 | $1,246 | $57 |
| Irbesartan | 13 | $910 | $70 |
| Pravastatin | 42 | $874 | $21 |
| Furosemide | 90 | $777 | $9 |
| Sotalol | 16 | $776 | $49 |
| Nitroglycerin | 26 | $757 | $29 |
| Simvastatin | 67 | $691 | $10 |
| Chlorthalidone | 21 | $649 | $31 |
| Hydralazine | 21 | $550 | $26 |
| Isosorbide Mononitrate Er | 30 | $545 | $18 |
| Lisinopril | 59 | $491 | $8 |
| Spironolactone | 34 | $407 | $12 |
| Tamsulosin | 12 | $347 | $29 |
| Metoprolol | 18 | $205 | $11 |
| Lovastatin | 12 | $184 | $15 |
| Hydrochlorothiazide | 38 | $183 | $5 |
| Metformin | 18 | $61 | $3 |
2022: 34 drugs
| Eliquis | 181 | $253,163 | $1,399 |
| Xarelto | 188 | $244,223 | $1,299 |
| Multaq | 26 | $51,220 | $1,970 |
| Entresto | 33 | $48,733 | $1,477 |
| Ezetimibe | 81 | $6,351 | $78 |
| Metoprolol | 274 | $5,403 | $20 |
| Atorvastatin | 301 | $4,754 | $16 |
| Amiodarone | 78 | $4,423 | $57 |
| Rosuvastatin | 94 | $3,639 | $39 |
| Labetalol | 28 | $2,550 | $91 |
| Losartan | 157 | $2,278 | $15 |
| Clopidogrel | 125 | $1,970 | $16 |
| Amlodipine Besylate | 202 | $1,881 | $9 |
| Carvedilol | 103 | $1,752 | $17 |
| Losartan-Hydrochlorothiazide | 48 | $1,217 | $25 |
| Irbesartan | 19 | $948 | $50 |
| Pantoprazole | 61 | $925 | $15 |
| Sotalol | 19 | $881 | $46 |
| Isosorbide Mononitrate Er | 19 | $874 | $46 |
| Simvastatin | 83 | $864 | $10 |
| Diltiazem 24hr Er (Cd) | 24 | $833 | $35 |
| Furosemide | 97 | $814 | $8 |
| Chlorthalidone | 15 | $685 | $46 |
| Pravastatin | 29 | $676 | $23 |
| Nitroglycerin | 34 | $577 | $17 |
| Warfarin | 20 | $461 | $23 |
| Lisinopril | 66 | $428 | $6 |
| Spironolactone | 24 | $372 | $16 |
| Hydralazine | 12 | $298 | $25 |
| Metoprolol | 23 | $214 | $9 |
| Allopurinol | 12 | $194 | $16 |
| Metformin | 14 | $186 | $13 |
| Hydrochlorothiazide | 32 | $128 | $4 |
| Atenolol | 13 | $83 | $6 |
2021: 33 drugs
| Xarelto | 150 | $206,346 | $1,376 |
| Eliquis | 122 | $166,730 | $1,367 |
| Multaq | 19 | $37,121 | $1,954 |
| Entresto | 26 | $34,555 | $1,329 |
| Ezetimibe | 63 | $8,374 | $133 |
| Metoprolol | 233 | $5,963 | $26 |
| Rosuvastatin | 93 | $5,168 | $56 |
| Atorvastatin | 265 | $4,741 | $18 |
| Amiodarone | 53 | $2,646 | $50 |
| Losartan | 133 | $2,034 | $15 |
| Clopidogrel | 128 | $1,872 | $15 |
| Carvedilol | 125 | $1,804 | $14 |
| Losartan-Hydrochlorothiazide | 45 | $1,759 | $39 |
| Labetalol | 18 | $1,660 | $92 |
| Diltiazem 24hr Er (Cd) | 20 | $1,603 | $80 |
| Amlodipine Besylate | 147 | $1,522 | $10 |
| Irbesartan | 13 | $1,234 | $95 |
| Simvastatin | 88 | $980 | $11 |
| Bisoprolol | 12 | $894 | $74 |
| Isosorbide Mononitrate Er | 19 | $803 | $42 |
| Sotalol | 16 | $727 | $45 |
| Pravastatin | 26 | $603 | $23 |
| Lisinopril | 62 | $522 | $8 |
| Warfarin | 25 | $518 | $21 |
| Pantoprazole | 39 | $499 | $13 |
| Furosemide | 68 | $442 | $7 |
| Metoprolol | 28 | $373 | $13 |
| Hydrochlorothiazide | 48 | $349 | $7 |
| Albuterol Sulfate Hfa | 11 | $313 | $28 |
| Nitroglycerin | 13 | $222 | $17 |
| Hydralazine | 13 | $189 | $15 |
| Metformin | 15 | $156 | $10 |
| Atenolol | 15 | $154 | $10 |
2020: 28 drugs
| Xarelto | 175 | $205,413 | $1,174 |
| Eliquis | 82 | $106,748 | $1,302 |
| Multaq | 16 | $29,365 | $1,835 |
| Entresto | 21 | $25,528 | $1,216 |
| Metoprolol | 171 | $5,194 | $30 |
| Atorvastatin | 212 | $4,873 | $23 |
| Ezetimibe | 50 | $4,869 | $97 |
| Rosuvastatin | 71 | $4,868 | $69 |
| Diltiazem 24hr Er (Cd) | 21 | $3,009 | $143 |
| Amiodarone | 47 | $2,396 | $51 |
| Labetalol | 17 | $2,196 | $129 |
| Losartan-Hydrochlorothiazide | 31 | $1,827 | $59 |
| Losartan | 92 | $1,563 | $17 |
| Clopidogrel | 88 | $1,541 | $18 |
| Olmesartan Medoxomil | 23 | $1,346 | $59 |
| Carvedilol | 107 | $1,190 | $11 |
| Amlodipine Besylate | 131 | $1,141 | $9 |
| Simvastatin | 83 | $930 | $11 |
| Isosorbide Mononitrate Er | 20 | $903 | $45 |
| Pantoprazole | 28 | $661 | $24 |
| Warfarin | 16 | $600 | $38 |
| Lisinopril | 56 | $510 | $9 |
| Pravastatin | 15 | $383 | $26 |
| Nitroglycerin | 14 | $318 | $23 |
| Furosemide | 50 | $263 | $5 |
| Hydrochlorothiazide | 43 | $241 | $6 |
| Atenolol | 15 | $162 | $11 |
| Hydralazine | 13 | $115 | $9 |
2019: 25 drugs
| Xarelto | 137 | $142,813 | $1,042 |
| Eliquis | 67 | $77,548 | $1,157 |
| Multaq | 24 | $38,467 | $1,603 |
| Brilinta | 23 | $12,813 | $557 |
| Metoprolol | 114 | $5,486 | $48 |
| Atorvastatin | 164 | $4,165 | $25 |
| Rosuvastatin | 36 | $2,933 | $81 |
| Clopidogrel | 96 | $1,644 | $17 |
| Labetalol | 12 | $1,522 | $127 |
| Ezetimibe | 22 | $1,517 | $69 |
| Carvedilol | 75 | $1,131 | $15 |
| Warfarin | 25 | $963 | $39 |
| Isosorbide Mononitrate Er | 17 | $924 | $54 |
| Losartan | 56 | $799 | $14 |
| Amlodipine Besylate | 89 | $745 | $8 |
| Simvastatin | 88 | $641 | $7 |
| Pravastatin | 15 | $596 | $40 |
| Amiodarone | 20 | $543 | $27 |
| Lisinopril | 50 | $402 | $8 |
| Pantoprazole | 24 | $348 | $15 |
| Losartan-Hydrochlorothiazide | 26 | $316 | $12 |
| Furosemide | 32 | $276 | $9 |
| Atenolol | 19 | $256 | $13 |
| Nitroglycerin | 15 | $251 | $17 |
| Hydrochlorothiazide | 27 | $173 | $6 |
2018: 25 drugs
| Xarelto | 146 | $124,036 | $850 |
| Eliquis | 48 | $56,795 | $1,183 |
| Multaq | 23 | $37,305 | $1,622 |
| Brilinta | 23 | $14,677 | $638 |
| Metoprolol | 113 | $5,352 | $47 |
| Atorvastatin | 166 | $4,593 | $28 |
| Rosuvastatin | 26 | $2,343 | $90 |
| Ezetimibe | 20 | $1,833 | $92 |
| Clopidogrel | 97 | $1,773 | $18 |
| Carvedilol | 69 | $846 | $12 |
| Pravastatin | 21 | $787 | $37 |
| Isosorbide Mononitrate Er | 14 | $717 | $51 |
| Simvastatin | 99 | $716 | $7 |
| Losartan | 48 | $557 | $12 |
| Amlodipine Besylate | 84 | $551 | $7 |
| Warfarin | 16 | $504 | $31 |
| Nitroglycerin | 21 | $468 | $22 |
| Amiodarone | 24 | $463 | $19 |
| Lisinopril | 47 | $420 | $9 |
| Losartan-Hydrochlorothiazide | 28 | $390 | $14 |
| Valsartan | 11 | $304 | $28 |
| Hydrochlorothiazide | 31 | $289 | $9 |
| Pantoprazole | 18 | $259 | $14 |
| Atenolol | 24 | $170 | $7 |
| Furosemide | 15 | $123 | $8 |
2017: 24 drugs
| Xarelto | 106 | $76,724 | $724 |
| Eliquis | 41 | $35,003 | $854 |
| Multaq | 19 | $22,294 | $1,173 |
| Metoprolol | 103 | $4,706 | $46 |
| Atorvastatin | 179 | $4,675 | $26 |
| Clopidogrel | 102 | $1,761 | $17 |
| Digox | 11 | $1,239 | $113 |
| Amiodarone | 41 | $1,161 | $28 |
| Carvedilol | 78 | $1,076 | $14 |
| Pravastatin | 28 | $1,055 | $38 |
| Warfarin | 43 | $1,019 | $24 |
| Simvastatin | 110 | $995 | $9 |
| Rosuvastatin | 11 | $658 | $60 |
| Isosorbide Mononitrate Er | 12 | $510 | $43 |
| Amlodipine Besylate | 65 | $497 | $8 |
| Sotalol | 18 | $472 | $26 |
| Losartan | 39 | $439 | $11 |
| Hydrochlorothiazide | 49 | $410 | $8 |
| Losartan-Hydrochlorothiazide | 26 | $379 | $15 |
| Lisinopril | 45 | $352 | $8 |
| Furosemide | 29 | $250 | $9 |
| Atenolol | 37 | $222 | $6 |
| Metoprolol | 23 | $161 | $7 |
| Benazepril | 14 | $143 | $10 |
2016: 26 drugs
| Xarelto | 103 | $72,669 | $706 |
| Multaq | 23 | $22,687 | $986 |
| Zetia | 23 | $18,464 | $803 |
| Eliquis | 21 | $14,259 | $679 |
| Atorvastatin | 181 | $4,898 | $27 |
| Metoprolol | 72 | $2,945 | $41 |
| Amiodarone | 55 | $2,752 | $50 |
| Clopidogrel | 143 | $2,127 | $15 |
| Digox | 16 | $1,178 | $74 |
| Carvedilol | 79 | $1,087 | $14 |
| Warfarin | 35 | $1,051 | $30 |
| Simvastatin | 126 | $998 | $8 |
| Pravastatin | 20 | $790 | $39 |
| Amlodipine Besylate | 66 | $652 | $10 |
| Lisinopril | 58 | $520 | $9 |
| Losartan | 38 | $407 | $11 |
| Nitrostat | 15 | $397 | $26 |
| Sotalol | 13 | $341 | $26 |
| Atenolol | 33 | $248 | $8 |
| Losartan-Hydrochlorothiazide | 19 | $182 | $10 |
| Hydrochlorothiazide | 34 | $167 | $5 |
| Benazepril | 13 | $148 | $11 |
| Pantoprazole | 11 | $139 | $13 |
| Metoprolol | 25 | $125 | $5 |
| Famotidine | 14 | $120 | $9 |
| Furosemide | 18 | $74 | $4 |
2015: 26 drugs
| Xarelto | 121 | $74,964 | $620 |
| Zetia | 31 | $17,593 | $568 |
| Multaq | 23 | $14,282 | $621 |
| Eliquis | 12 | $8,024 | $669 |
| Atorvastatin | 165 | $4,400 | $27 |
| Metoprolol | 78 | $3,309 | $42 |
| Amiodarone | 74 | $3,202 | $43 |
| Clopidogrel | 163 | $2,180 | $13 |
| Digox | 23 | $1,953 | $85 |
| Warfarin | 40 | $1,186 | $30 |
| Carvedilol | 81 | $850 | $10 |
| Simvastatin | 124 | $831 | $7 |
| Pravastatin | 16 | $740 | $46 |
| Amlodipine Besylate | 73 | $619 | $8 |
| Sotalol | 13 | $471 | $36 |
| Lisinopril | 70 | $461 | $7 |
| Losartan | 43 | $435 | $10 |
| Pantoprazole | 22 | $381 | $17 |
| Losartan-Hydrochlorothiazide | 20 | $286 | $14 |
| Nitrostat | 14 | $269 | $19 |
| Metoprolol | 33 | $233 | $7 |
| Hydrochlorothiazide | 36 | $173 | $5 |
| Benazepril | 11 | $149 | $14 |
| Atenolol | 31 | $140 | $5 |
| Famotidine | 13 | $113 | $9 |
| Furosemide | 22 | $110 | $5 |
2014: 27 drugs
| Xarelto | 69 | $43,377 | $629 |
| Multaq | 19 | $10,819 | $569 |
| Zetia | 22 | $8,832 | $401 |
| Atorvastatin | 177 | $5,649 | $32 |
| Metoprolol | 101 | $5,547 | $55 |
| Diovan | 13 | $4,717 | $363 |
| Clopidogrel | 179 | $3,265 | $18 |
| Digox | 22 | $1,681 | $76 |
| Micardis Hct | 11 | $1,672 | $152 |
| Carvedilol | 107 | $1,671 | $16 |
| Simvastatin | 144 | $1,281 | $9 |
| Warfarin | 64 | $1,195 | $19 |
| Amiodarone | 53 | $1,094 | $21 |
| Losartan | 39 | $846 | $22 |
| Sotalol | 16 | $827 | $52 |
| Amlodipine Besylate | 68 | $792 | $12 |
| Pravastatin | 15 | $772 | $51 |
| Losartan-Hydrochlorothiazide | 23 | $764 | $33 |
| Lisinopril | 76 | $535 | $7 |
| Lovastatin | 12 | $275 | $23 |
| Pantoprazole | 12 | $251 | $21 |
| Metoprolol | 37 | $247 | $7 |
| Atenolol | 37 | $240 | $6 |
| Tramadol | 19 | $193 | $10 |
| Famotidine | 17 | $164 | $10 |
| Hydrochlorothiazide | 23 | $153 | $7 |
| Furosemide | 33 | $132 | $4 |
2013: 30 drugs
| Xarelto | 55 | $28,729 | $522 |
| Clopidogrel | 212 | $13,779 | $65 |
| Multaq | 14 | $8,910 | $636 |
| Atorvastatin | 184 | $7,667 | $42 |
| Pradaxa | 11 | $6,562 | $597 |
| Metoprolol | 106 | $5,487 | $52 |
| Diovan | 24 | $4,934 | $206 |
| Crestor | 18 | $4,666 | $259 |
| Zetia | 12 | $3,502 | $292 |
| Simvastatin | 175 | $2,018 | $12 |
| Carvedilol | 96 | $1,728 | $18 |
| Warfarin | 98 | $1,589 | $16 |
| Amiodarone | 45 | $1,551 | $34 |
| Losartan | 37 | $1,130 | $31 |
| Sotalol | 18 | $902 | $50 |
| Lisinopril | 102 | $870 | $9 |
| Amlodipine Besylate | 63 | $815 | $13 |
| Losartan-Hydrochlorothiazide | 25 | $810 | $32 |
| Pravastatin | 19 | $464 | $24 |
| Digox | 28 | $456 | $16 |
| Flecainide Acetate | 11 | $453 | $41 |
| Metoprolol | 35 | $392 | $11 |
| Lovastatin | 18 | $391 | $22 |
| Atenolol | 28 | $244 | $9 |
| Hydrochlorothiazide | 35 | $219 | $6 |
| Tramadol | 12 | $135 | $11 |
| Nitrostat | 11 | $128 | $12 |
| Furosemide | 40 | $123 | $3 |
| Famotidine | 13 | $118 | $9 |
| Ranitidine | 13 | $65 | $5 |
Money from drug and device companies
$299 in 2025
| 2025 | 7 | 16 | None | $299 |
| 2024 | 5 | 6 | $275 | $419 |
| 2023 | 6 | 6 | $67 | $182 |
| 2022 | 4 | 9 | $300 | $478 |
| 2021 | 8 | 20 | $625 | $1,108 |
| 2020 | 8 | 14 | $450 | $719 |
| 2019 | 12 | 37 | $3,888 | $5,600 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $175 | 10 payments
|
| Pfizer | Vyndaqel | $24 | 1 payment
|
| Esperion Therapeutics | Nexletol | $24 | 1 payment
|
| Abbott Laboratories | Triclip | $23 | 1 payment
|
| Octapharma USA | Balfaxar | $18 | 1 payment
|
| Cordis US | Mynx Control Venous | $17 | 1 payment
|
See all 16 published payments
| Boston Scientific | Meals · 2025-11-26 | Ranger | $17 |
| Baxter Healthcare | Meals · 2025-11-20 | Hillrom - Carnation Ambulatory Monitor | $9 |
| Cordis US | Meals · 2025-11-06 | Mynx Control Venous | $17 |
| Baxter Healthcare | Meals · 2025-10-23 | Hillrom - Carnation Ambulatory Monitor | $23 |
| Baxter Healthcare | Meals · 2025-10-15 | Hillrom - Cardiac Ambulatory Monitor | $12 |
| Baxter Healthcare | Meals · 2025-09-08 | Hillrom - Carnation Ambulatory Monitor | $13 |
| Octapharma USA | Meals · 2025-08-19 | Balfaxar | $18 |
| Baxter Healthcare | Meals · 2025-08-11 | Hillrom - Carnation Ambulatory Monitor | $21 |
| Baxter Healthcare | Meals · 2025-07-30 | Hillrom - Carnation Ambulatory Monitor | $21 |
| Abbott Laboratories | Meals · 2025-07-08 | Triclip | $23 |
| Baxter Healthcare | Meals · 2025-06-28 | Hillrom - Carnation Ambulatory Monitor | $10 |
| Baxter Healthcare | Meals · 2025-05-23 | Hillrom - Carnation Ambulatory Monitor | $14 |
| Pfizer | Meals · 2025-05-21 | Vyndaqel | $24 |
| Baxter Healthcare | Meals · 2025-03-28 | Hillrom - Carnation Ambulatory Monitor | $22 |
| Baxter Healthcare | Meals · 2025-02-04 | Hillrom - Carnation Ambulatory Monitor | $30 |
| Esperion Therapeutics | Meals · 2025-01-28 | Nexletol | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $419
| Ge Healthcare | Viewpoint | $275 | 1 payment
|
| Abbott Laboratories | Assurity | $58 | 2 payments
|
| Boston Scientific | Jetstream Sc | $44 | 1 payment
|
| Novo Nordisk | Ozempic | $24 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $18 | 1 payment
|
2023: $182
| Medtronic | Telescope | $67 | 1 payment
|
| Pfizer | Eliquis | $29 | 1 payment
|
| Abbott Laboratories | Jot Dx | $25 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $24 | 1 payment
|
| Lexicon Pharmaceuticals | Inpefa | $21 | 1 payment
|
| Penumbra | Indigo System | $15 | 1 payment
|
2022: $478
| Sanofi-Aventis U.S. | Multaq | $326 | 2 payments
|
| Amgen | Repatha | $79 | 4 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $60 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $12 | 1 payment
|
2021: $1,108
| Sanofi-Aventis U.S. | Multaq | $600 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $175 | 7 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $133 | 5 payments
|
| Abiomed | Impella | $82 | 2 payments
|
| Medtronic | Launcher | $45 | 2 payments
|
| Amgen | Repatha | $26 | 1 payment
|
| Abbott Laboratories | Cardiomems Hf System | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
2020: $719
| Sanofi-Aventis U.S. | Multaq | $450 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $79 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $69 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $32 | 2 payments
|
| Abiomed | Impella | $29 | 1 payment
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $24 | 1 payment
|
| Boston Scientific | General - Thrombectomy | $21 | 1 payment
|
| Amgen | Repatha | $15 | 1 payment
|
2019: $5,600
| Sanofi US Services | No Product Discussed | $4,197 | 6 payments
|
| Sanofi-Aventis U.S. | Multaq | $800 | 2 payments
|
| Amgen | Repatha | $189 | 7 payments
|
| Novartis Pharmaceuticals | Entresto | $79 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $74 | 4 payments
|
| Boston Scientific | Watchman | $65 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $52 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $52 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $39 | 2 payments
|
| Abbott Laboratories | Mitra Clip System | $24 | 1 payment
|
| HeartFlow | None | $16 | 1 payment
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134143506
- Licence
- CA G75949California G75949: Current · expires 2028-11-30
- Trained
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 1991 · 35 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G759490
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2250 Hayes St, Suite 204, San Francisco, CA, 94117
- NPI first listed
- 2006-07-27
- NPI last updated
- 2008-04-25
This is when the NPI record was last certified, not a medical board exam.